Omalizumab 150mg Injection

Omalizumab 150mg Injection is a monoclonal antibody therapy used for the treatment of moderate to severe allergic asthma and chronic spontaneous urticaria (chronic hives). It works by targeting immunoglobulin E (IgE), a key substance involved in allergic reactions. By reducing IgE activity, omalizumab helps prevent inflammation and allergic responses that trigger asthma symptoms and skin reactions.

This advanced biologic therapy is prescribed for patients whose asthma symptoms remain uncontrolled despite standard inhaled medications. Omalizumab 150 mg injection helps decrease the frequency of asthma attacks, improve lung function, and reduce dependency on corticosteroids. It is also effective in controlling persistent itching, swelling, and skin eruptions associated with chronic urticaria.

Administered under medical supervision, Omalizumab 150mg Injection provides long-term allergy control and improved respiratory stability. Regular treatment helps enhance quality of life by minimizing severe allergic episodes and improving symptom management. The injection is typically given at scheduled intervals based on patient weight and IgE levels for optimal therapeutic outcomes.

Product Features

• Contains Omalizumab 150mg monoclonal antibody
• Targets IgE-mediated allergic reactions
• Helps control severe allergic asthma
• Effective in chronic spontaneous urticaria treatment
• Reduces frequency of asthma exacerbations

How It Helps

• Blocks allergic response triggers
• Reduces asthma attacks and symptoms
• Improves breathing and lung function
• Controls chronic hives and itching